Evidence map›Paper›PMID 38376772›Full record

ArticleCardiovascular toxicology2024

Uncovering the Mechanism of Chinese Hawthorn Leaf on Myocardial Ischemia Based on Network Pharmacology, Molecular Docking Verification, and In Vitro Studies.

Jingyun Gao, Yueyue Wang, Hui Xiong, Shengnan Zhao, Mingmei He, Meiting He, Haifeng Pan

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jingyun GaoHebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical College, Anyuan Road, Shuangqiao District, Chengde, 067000, Hebei, China.
Yueyue WangHebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical College, Anyuan Road, Shuangqiao District, Chengde, 067000, Hebei, China.
Hui XiongHebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical College, Anyuan Road, Shuangqiao District, Chengde, 067000, Hebei, China.
Shengnan ZhaoHebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical College, Anyuan Road, Shuangqiao District, Chengde, 067000, Hebei, China.
Mingmei HeHebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical College, Anyuan Road, Shuangqiao District, Chengde, 067000, Hebei, China.
Meiting HeHebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical College, Anyuan Road, Shuangqiao District, Chengde, 067000, Hebei, China.
Haifeng PanHebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical College, Anyuan Road, Shuangqiao District, Chengde, 067000, Hebei, China. phf2301@163.com.ORCID 0000-0002-1791-5827

Funding

Key discipline Construction Project of Colleges and Universities in Hebei Province (Grant number Ji Jiao Gao [2013] 4)the Provincial Science and Technology Plan of Hebei Province (Grant numbers 20372507D)
6 · The paper itself

Abstract

Hawthorn leaf has shown therapeutic effects in the patients with myocardial ischemia. Our study combines network pharmacology, molecular docking techniques, and in vitro experiment with the aim of revealing the mechanism of hawthorn leaves in the treatment of myocardial ischemia. The active ingredients and corresponding targets of hawthorn leaf through Traditional Chinese Medicine System Pharmacology and Swiss Target Prediction databases. Targets related to myocardial ischemia were retrieved by Gene Card, Online Mendelian Inheritance in Man, Disgenet, and Therapeutic Targets Database databases. Cytoscape software was used to construct an ingredient-target-organ network and enrichment analysis of common targets was analyzed. Molecular docking verification of the core compound and target interactions was performed using MOE software. In vitro cell experiment was performed to verify the findings from bioinformatics analysis. Six active components and 107 potential therapeutic targets were screened. The protein-protein interaction network analysis indicated that 10 targets, including AKT1 and EGFR, were hub genes. Quercetin, kaempferol and isorhamnetin were taken as core active components. Through pathway enrichment analysis, nearly 455 Gene Ontology entries and 77 Kyoto Encyclopedia of Genes and Genomes pathways were obtained, mainly including PI3K/Akt, estrogen and other signaling pathways. Molecular docking prediction showed that three main active ingredients were firmly combined with the core targets. Cellular experiments showed that quercetin alleviated oxidative damage in cells and regulated the expression of PI3K, P-AKT/AKT and Bax/Bcl-2 proteins. This study identified the potential targets of Hawthorn leaf against myocardial ischemia using network pharmacology and in vitro verification, which provided a new understanding of the pharmacological mechanisms of Hawthorn leaf in treatment of myocardial ischemia.

Indexed as

Coronary Artery DiseaseCrataegusDrugs, Chinese HerbalMyocardial IschemiaDatabases, GeneticHumansMolecular Docking SimulationNetwork PharmacologyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktQuercetinDrugs, Chinese HerbalPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktQuercetinExperimental verificationHawthorn leafMolecular docking verificationMyocardial ischemiaNetwork pharmacology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.